A 45-year-old woman on oral contraceptives with a 3-day history of progressive dyspnea and unilateral leg swelling is suspected to have pulmonary embolism. Regarding diagnostic approaches and risk stratification in PE, all of the following statements are correct EXCEPT:

Explanation

## Diagnostic Approaches and Risk Stratification in PE ### Key Point: **Statement B is the EXCEPT answer — it is factually incorrect as written.** Option B states: *"Elevated lactate and hypoxemia with normal A-a gradient suggest alternative diagnoses and lower the pretest probability of PE."* This statement conflates two separate concepts in a misleading and factually erroneous way: 1. **Elevated lactate in PE:** Elevated lactate is a marker of tissue hypoperfusion and is actually associated with **massive/high-risk PE** (right heart failure, cardiogenic shock). It does NOT lower pretest probability of PE — it raises concern for severe PE. (Harrison's 21e, Ch. 297) 2. **Normal A-a gradient with hypoxemia:** A normal alveolar-arterial (A-a) gradient despite hypoxemia does suggest a non-pulmonary cause (e.g., hypoventilation, low inspired O₂, central causes) — but this is a separate finding from elevated lactate. Combining "elevated lactate" (which points toward severe PE) with "normal A-a gradient" (which may suggest alternative diagnoses) into a single statement that "lowers pretest probability of PE" is factually incoherent and misleading. The net effect: **elevated lactate in the context of suspected PE should raise, not lower, concern for PE.** The statement as written is incorrect. --- ### Why the Other Options Are Correct (TRUE statements): **Statement A (Wells/PERC):** TRUE — Wells score and PERC criteria are validated, widely used clinical decision rules for pretest probability stratification in PE. (Harrison's 21e, Ch. 297) **Statement C (V/Q scan preference):** TRUE — V/Q scan is preferred over CTPA in patients with renal insufficiency (avoids contrast nephropathy) or contrast allergy. CTPA remains preferred when renal function is normal. (Harrison's 21e, Ch. 297) **Statement D (Hampton's hump / Westermark sign):** TRUE that these are classic CXR findings in PE, BUT the statement says they are "highly specific" and "can be used to exclude other diagnoses" — this is actually FALSE, making D a candidate EXCEPT answer. However, Statement B is MORE clearly and unambiguously incorrect because elevated lactate actively suggests severe PE rather than lowering pretest probability. --- ### High-Yield CXR Findings in PE: | Finding | Frequency | Specificity | Clinical Use | |---------|-----------|-------------|--------------| | Hampton's hump (wedge opacity) | 10–15% | Low | Suggests infarction, not diagnostic | | Westermark sign (oligemia) | 5–10% | Low | Suggests emboli, not diagnostic | | Normal CXR | ~25% of PE | N/A | Does NOT exclude PE | > **Note:** CXR is used to exclude mimics (pneumonia, pneumothorax), not to diagnose PE. ### Clinical Pearl: - **Elevated lactate in PE** = marker of severity (massive PE with hemodynamic compromise), NOT a finding that lowers PE probability. - **Normal A-a gradient with hypoxemia** = suggests hypoventilation or non-pulmonary cause — but this is distinct from elevated lactate. - **D-dimer** has >95% sensitivity; useful to exclude PE in low-probability patients. [cite: Harrison's Principles of Internal Medicine, 21e, Ch. 297 — Pulmonary Thromboembolism]